Free Trial
→ I was right about SpaceX (From Brownstone Research) (Ad)tc pixel Free SCSC Stock Alerts

ScanSource (SCSC) Financials

ScanSource logo
$46.67 +0.85 (+1.86%)
As of 01:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for ScanSource

Annual Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 65 64 69 33 58 -193 11 89 90 77 72
Consolidated Net Income / (Loss)		 65 64 69 33 58 -193 11 89 90 77 72
Net Income / (Loss) Continuing Operations		 65 64 69 35 65 -79 45 89 88 77 72
Total Pre-Tax Income 		100 96 101 63 84 -72 58 119 122 100 94
Total Operating Income		 101 97 88 69 95 -65 61 122 136 90 85
Total Gross Profit		 327 355 384 369 393 356 351 427 449 399 409
Total Revenue		 3,219 3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260 3,041
Operating Revenue		 3,219 3,540 3,568 3,165 3,250 3,048 3,151 3,530 3,788 3,260 3,041
Total Cost of Revenue		 2,892 3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861 2,632
Operating Cost of Revenue		 2,892 3,185 3,185 2,795 2,857 2,692 2,800 3,103 3,338 2,861 2,632
Total Operating Expenses		 226 259 295 300 298 421 289 304 313 309 323
Selling, General & Admin Expense		 211 240 265 232 244 260 247 275 286 277 287
Depreciation Expense		 5.36 7.33 9.40 12 12 13 13 11 11 11 10
Amortization Expense		 6.60 9.80 16 19 18 20 19 18 17 16 19
Restructuring Charge		 - - - - 8.65 0.60 9.26 0.00 0.00 4.36 5.38
Other Special Charges / (Income)		 2.67 1.29 5.21 37 15 6.94 0.52 - 0.00 0.00 1.90
Total Other Income / (Expense), net		 -1.54 -0.87 13 -5.96 -11 -6.81 -3.95 -3.54 -14 9.52 9.20
Interest Expense		 1.80 2.12 3.22 9.12 13 12 6.93 6.52 20 13 8.01
Interest & Investment Income		 2.64 3.45 5.33 3.71 1.82 5.83 3.10 4.33 7.41 9.38 11
Other Income / (Expense), net		 -2.38 -2.19 11 -0.55 0.25 -0.41 -0.12 -1.35 -1.66 13 5.96
Income Tax Expense		 34 32 32 28 19 7.45 12 30 34 23 23
Net Income / (Loss) Discontinued Operations		 - - - -2.30 -7.26 -113 -35 0.10 1.72 0.00 0.00
Basic Earnings per Share		 $2.29 $2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10 $3.05
Weighted Average Basic Shares Outstanding		 28.56M 26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M 23.44M
Diluted Earnings per Share		 $2.27 $2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06 $3.00
Weighted Average Diluted Shares Outstanding		 28.80M 26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M 23.84M
Weighted Average Basic & Diluted Shares Outstanding		 28.60M 26.50M 25.30M 25.50M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M 21.88M

Quarterly Income Statements for ScanSource

This table shows ScanSource's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 15 33 13 16 17 17 17 20 20 16 17
Consolidated Net Income / (Loss)		 15 33 13 16 17 17 17 20 20 16 17
Net Income / (Loss) Continuing Operations		 15 33 13 16 17 17 17 20 20 16 17
Total Pre-Tax Income 		19 40 18 23 23 20 24 27 27 19 24
Total Operating Income		 24 27 18 22 18 18 22 27 26 18 23
Total Gross Profit		 107 101 94 97 102 102 100 105 107 103 107
Total Revenue		 876 885 753 746 776 747 705 813 740 767 767
Operating Revenue		 876 885 753 746 776 747 705 813 740 767 767
Total Cost of Revenue		 770 784 658 649 674 646 605 708 632 664 660
Operating Cost of Revenue		 770 784 658 649 674 646 605 708 632 664 660
Total Operating Expenses		 82 74 77 75 84 83 78 78 82 85 84
Selling, General & Admin Expense		 75 67 67 68 72 74 70 72 75 78 78
Depreciation Expense		 2.80 2.96 2.69 2.77 2.86 2.90 2.32 1.93 1.58 1.43 1.50
Amortization Expense		 4.19 4.04 3.75 3.74 4.36 5.00 4.94 4.93 4.40 4.29 4.00
Restructuring Charge		 0.00 0.00 3.92 - 5.07 0.31 0.00 - 0.00 0.00 0.00
Other Special Charges / (Income)		 - 0.00 0.00 - 0.00 1.14 0.90 - 0.31 1.21 0.44
Total Other Income / (Expense), net		 -4.94 13 0.41 0.82 5.33 1.27 1.89 0.71 1.09 1.55 0.93
Interest Expense		 5.59 3.36 2.00 2.09 2.11 1.97 1.84 2.10 1.91 1.95 1.30
Interest & Investment Income		 1.33 2.12 2.65 3.29 2.66 2.69 2.84 3.05 3.18 3.36 2.45
Other Income / (Expense), net		 -0.68 14 -0.24 -0.38 4.78 0.54 0.88 -0.25 -0.17 0.14 -0.22
Income Tax Expense		 3.72 7.32 5.15 6.60 5.99 2.66 6.80 7.41 7.12 2.93 7.17
Basic Earnings per Share		 $0.62 $1.31 $0.51 $0.66 $0.70 $0.72 $0.75 $0.88 $0.90 $0.75 $0.79
Weighted Average Basic Shares Outstanding		 24.89M 25.04M 25.03M 24.87M 24.15M 23.81M 23.28M 23.44M 22.02M 21.87M 21.31M
Diluted Earnings per Share		 $0.61 $1.29 $0.50 $0.66 $0.69 $0.70 $0.74 $0.87 $0.89 $0.75 $0.78
Weighted Average Diluted Shares Outstanding		 25.18M 25.33M 25.44M 25.22M 24.65M 24.22M 23.60M 23.84M 22.41M 22.11M 21.58M
Weighted Average Basic & Diluted Shares Outstanding		 24.97M 25.17M 24.71M 24.03M 0.00 23.46M 22.60M 21.88M 21.94M 21.48M 20.32M

Annual Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 -73 -60 -4.87 -35 -1.71 11 28 -25 -1.81 149 -59
Net Cash From Operating Activities		 76 52 95 25 16 182 117 -124 -36 372 112
Net Cash From Continuing Operating Activities		 76 52 95 31 16 182 117 -124 -36 372 112
Net Income / (Loss) Continuing Operations		 65 64 69 35 65 -79 45 89 88 77 72
Consolidated Net Income / (Loss)		 65 64 69 33 58 -193 11 89 90 77 72
Net Income / (Loss) Discontinued Operations		 - - - -2.30 -7.26 -113 -35 0.10 1.72 0.00 0.00
Depreciation Expense		 12 17 25 34 34 35 34 30 29 28 30
Amortization Expense		 0.30 0.30 0.29 0.33 0.35 0.42 0.42 0.42 0.58 0.39 0.39
Non-Cash Adjustments To Reconcile Net Income		 7.26 15 15 9.44 -2.43 125 5.96 13 14 3.80 19
Changes in Operating Assets and Liabilities, net		 -9.45 -43 -15 -48 -80 101 31 -257 -167 262 -9.28
Net Cash From Discontinued Operating Activities		 - - - -6.64 - - - 0.00 0.00 0.00 0.00
Net Cash From Investing Activities		 -81 -74 -96 -152 -38 -55 32 -3.72 -8.26 9.05 -62
Net Cash From Continuing Investing Activities		 -81 -74 -96 -151 -38 -55 32 -3.72 -8.26 9.05 -62
Purchase of Property, Plant & Equipment		 -21 -12 -8.85 -7.00 -5.80 -6.39 -2.36 -6.85 -9.98 -8.56 -8.29
Acquisitions		 -60 -61 -87 -144 -32 -49 - - 0.00 0.00 -57
Divestitures		 - - - - 0.00 0.00 34 3.13 1.72 18 2.57
Net Cash From Discontinued Investing Activities		 - - - -1.16 - - - 0.00 0.00 0.00 0.00
Net Cash From Financing Activities		 -57 -36 -3.51 101 31 -153 -119 108 40 -228 -111
Net Cash From Continuing Financing Activities		 -57 -36 -3.51 101 31 -153 -119 108 40 -228 -111
Repayment of Debt		 -133 -1,308 -1,794 -2,150 -2,134 -2,196 -1,957 -2,040 -2,442 -1,447 -61
Repurchase of Common Equity		 -19 -100 -21 0.00 -9.48 -6.08 0.00 -18 -16 -43 -107
Issuance of Debt		 94 1,377 1,813 2,301 2,211 2,086 1,882 2,166 2,499 1,260 52
Other Financing Activities, net		 1.02 -4.51 -1.94 -50 -36 -36 -43 -0.45 -1.55 1.94 4.62
Net Cash From Discontinued Financing Activities		 - - - -0.35 - - - 0.00 0.00 0.00 0.00
Effect of Exchange Rate Changes		 -11 -2.60 - - 0.56 -3.64 3.71 -4.76 2.69 -3.64 1.64
Cash Interest Paid		 1.08 1.71 2.83 8.61 13 12 6.41 6.07 19 13 7.57
Cash Income Taxes Paid		 36 34 31 36 31 17 12 29 29 27 28

Quarterly Cash Flow Statements for ScanSource

This table details how cash moves in and out of ScanSource's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 6.47 2.34 114 26 -40 -35 36 -20 -1.23 -41 37
Net Cash From Operating Activities		 94 63 160 55 45 -6.19 66 7.65 23 31 71
Net Cash From Continuing Operating Activities		 94 63 160 55 45 -6.19 66 7.65 23 31 71
Net Income / (Loss) Continuing Operations		 15 33 13 16 17 17 17 20 20 16 17
Consolidated Net Income / (Loss)		 15 33 13 16 17 17 17 20 20 16 17
Depreciation Expense		 7.22 7.26 6.74 6.79 7.47 8.13 7.49 7.10 6.20 5.94 5.71
Amortization Expense		 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.34 0.09
Non-Cash Adjustments To Reconcile Net Income		 6.94 -12 3.80 4.67 4.17 7.29 4.69 3.34 4.82 7.33 3.77
Changes in Operating Assets and Liabilities, net		 64 35 137 27 16 -39 36 -23 -7.78 0.75 45
Net Cash From Investing Activities		 -2.32 15 -2.42 -1.65 -59 0.77 -1.42 -2.52 -2.40 -20 -2.26
Net Cash From Continuing Investing Activities		 -2.32 15 -2.42 -1.65 -59 0.77 -1.42 -2.52 -2.40 -20 -2.26
Purchase of Property, Plant & Equipment		 -2.32 -2.55 -2.42 -1.27 -2.38 -1.97 -1.42 -2.52 -2.40 -1.98 -2.40
Acquisitions		 0.00 - - - -57 0.18 - - 0.00 -18 0.14
Net Cash From Financing Activities		 -83 -78 -43 -24 -27 -26 -31 -27 -23 -50 -34
Net Cash From Continuing Financing Activities		 -83 -78 -43 -24 -27 -26 -31 -27 -23 -50 -34
Repayment of Debt		 -671 -626 -131 -19 -9.06 -22 -14 -16 -52 -225 -48
Repurchase of Common Equity		 0.00 -1.25 -20 -22 -28 -24 -29 -25 -21 -17 -33
Issuance of Debt		 589 546 108 17 8.38 18 12 14 49 193 48
Other Financing Activities, net		 -1.51 3.16 0.18 0.11 2.18 2.51 0.00 -0.07 0.84 0.00 -0.22
Effect of Exchange Rate Changes		 -1.26 1.50 -1.03 -2.86 0.61 -3.38 2.19 2.22 0.90 -1.65 1.50

Annual Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets		 1,477 1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779 1,786
Total Current Assets		 1,244 1,229 1,281 1,362 1,477 1,203 1,220 1,524 1,657 1,405 1,370
Cash & Equivalents		 122 61 56 26 19 29 63 38 36 185 126
Accounts Receivable		 523 560 637 646 523 443 569 729 753 582 636
Inventories, net		 553 559 531 596 554 455 470 615 758 513 484
Prepaid Expenses		 47 49 56 95 84 95 118 142 110 125 122
Current Deferred & Refundable Income Taxes		 - - - - - - - - - - 2.82
Plant, Property, & Equipment, net		 47 52 57 73 0.00 0.00 0.00 0.00 0.00 34 31
Total Noncurrent Assets		 186 210 381 510 590 489 452 414 411 341 384
Goodwill		 67 93 201 298 311 214 219 214 217 206 231
Intangible Assets		 46 51 102 137 121 122 105 84 68 38 63
Noncurrent Deferred & Refundable Income Taxes		 39 29 29 22 15 25 22 16 18 20 19
Other Noncurrent Operating Assets		 34 37 49 53 113 128 106 99 108 77 71
Total Liabilities & Shareholders' Equity		 1,477 1,491 1,718 1,945 2,067 1,692 1,672 1,937 2,068 1,779 1,786
Total Liabilities		 668 717 881 1,079 1,153 1,014 940 1,131 1,163 855 879
Total Current Liabilities		 599 585 656 710 701 719 733 814 787 669 683
Short-Term Debt		 12 12 31 44 42 54 7.84 12 6.92 7.86 9.18
Accounts Payable		 501 471 513 563 488 454 635 714 691 588 599
Current Deferred & Payable Income Tax Liabilities		 4.18 3.06 7.73 13 3.96 5.89 2.50 0.03 9.88 7.90 3.93
Other Current Liabilities		 81 99 105 91 65 77 88 88 79 66 71
Total Noncurrent Liabilities		 69 132 225 369 452 295 208 317 376 185 196
Long-Term Debt		 5.97 77 97 249 323 211 135 260 323 136 128
Other Noncurrent Operating Liabilities		 59 52 126 118 97 80 68 54 49 49 68
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 809 774 837 866 914 678 731 807 905 924 906
Total Preferred & Common Equity		 809 774 837 866 914 678 731 807 905 924 906
Preferred Stock		 - - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 809 774 837 866 914 678 731 807 905 924 906
Common Stock		 157 67 61 68 64 64 71 64 58 26 0.00
Retained Earnings		 716 780 849 882 940 747 758 847 937 1,014 1,021
Accumulated Other Comprehensive Income / (Loss)		 -65 -73 -73 -84 -90 -133 -98 -105 -90 -116 -114

Quarterly Balance Sheets for ScanSource

This table presents ScanSource's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 12/31/2022 3/31/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 2,131 1,980 1,899 1,781 1,783 1,787 1,703 1,725 1,717 1,742 1,806
Total Current Assets		 1,719 1,578 1,507 1,405 1,416 1,352 1,284 1,310 1,307 1,303 1,372
Cash & Equivalents		 66 37 43 45 159 145 111 146 125 83 120
Accounts Receivable		 780 684 692 663 590 567 549 563 557 605 628
Inventories, net		 762 753 656 575 529 504 492 476 505 490 487
Prepaid Expenses		 111 103 117 122 138 136 132 125 120 113 126
Current Deferred & Refundable Income Taxes		 - - - - - - - - - 11 10
Plant, Property, & Equipment, net		 0.00 36 0.00 0.00 36 33 30 30 32 32 34
Total Noncurrent Assets		 411 366 391 376 331 401 389 385 377 406 400
Goodwill		 214 215 215 208 208 233 228 229 231 244 245
Intangible Assets		 76 72 64 45 42 78 73 68 59 72 68
Noncurrent Deferred & Refundable Income Taxes		 15 14 16 19 19 17 18 18 17 14 16
Other Noncurrent Operating Assets		 106 65 96 103 63 73 70 70 71 76 71
Total Liabilities & Shareholders' Equity		 2,131 1,980 1,899 1,781 1,783 1,787 1,703 1,725 1,717 1,742 1,806
Total Liabilities		 1,268 1,101 983 827 839 866 802 823 803 831 899
Total Current Liabilities		 837 744 701 611 643 666 610 632 606 664 737
Short-Term Debt		 5.04 5.98 8.21 7.86 7.86 12 9.90 9.60 9.65 19 19
Accounts Payable		 749 657 618 541 556 579 520 541 530 577 647
Current Deferred & Payable Income Tax Liabilities		 6.05 4.44 8.11 3.65 4.79 6.38 8.33 13 3.56 0.27 0.28
Other Current Liabilities		 77 77 67 58 75 69 71 68 63 68 71
Total Noncurrent Liabilities		 431 357 282 217 196 200 192 192 197 167 163
Long-Term Debt		 378 305 240 161 138 134 132 130 126 100 99
Other Noncurrent Operating Liabilities		 51 49 39 56 58 66 60 61 71 67 64
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 862 879 915 954 944 921 901 902 914 911 906
Total Preferred & Common Equity		 862 879 915 954 944 921 901 902 914 911 906
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 862 879 915 954 944 921 901 902 914 911 906
Common Stock		 68 60 60 64 46 2.98 0.00 0.00 0.00 0.00 0.00
Retained Earnings		 897 918 952 985 998 1,031 1,032 1,023 1,025 1,027 1,015
Accumulated Other Comprehensive Income / (Loss)		 -103 -99 -96 -95 -100 -113 -131 -122 -111 -116 -109

Annual Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.47% 9.99% 0.79% -11.31% 2.69% -6.22% 3.38% 12.03% 7.30% -13.94% -6.72%
EBITDA Growth		 -13.78% 0.70% 11.15% -17.14% 24.89% -122.97% 421.57% 58.58% 8.14% -19.29% -7.69%
EBIT Growth		 -18.45% -4.42% 4.96% -31.11% 38.74% -168.83% 193.86% 96.87% 11.10% -22.90% -11.91%
NOPAT Growth		 -17.91% -3.36% -6.22% -35.54% 89.31% -161.90% 206.66% 88.33% 7.54% -29.04% -7.37%
Net Income Growth		 -20.01% -2.75% 8.84% -52.12% 73.73% -434.49% 105.60% 722.58% 1.14% -14.20% -7.15%
EPS Growth		 -20.63% 4.85% 13.87% -52.40% 73.64% -438.84% 105.53% 721.43% 2.61% -13.56% -1.96%
Operating Cash Flow Growth		 58.25% -30.87% 81.72% -73.85% -35.37% 1,035.44% -35.85% -206.50% 71.24% 1,139.02% -69.77%
Free Cash Flow Firm Growth		 -206.74% -58.51% -48.69% -292.19% 174.51% 17.60% -40.01% -240.26% 55.33% 731.87% -92.30%
Invested Capital Growth		 13.97% 13.60% 13.41% 24.67% -5.71% -19.46% -5.69% 28.10% 15.32% -26.37% 3.95%
Revenue Q/Q Growth		 3.16% 0.59% 1.13% -16.05% 0.78% 10.87% 7.37% 3.20% -0.40% -5.81% 2.25%
EBITDA Q/Q Growth		 -10.73% -5.16% 4.66% -0.64% 3.06% -127.79% 332.09% 2.03% -0.16% -4.28% 4.60%
EBIT Q/Q Growth		 -13.42% -6.64% 4.05% -1.01% 4.42% -188.87% 181.14% 2.89% 0.15% -4.99% 5.86%
NOPAT Q/Q Growth		 -13.46% -4.95% 8.26% -11.92% 12.45% -180.86% 192.09% -0.06% -1.05% -6.15% 6.68%
Net Income Q/Q Growth		 -14.01% -5.25% 9.56% -20.56% 2.11% -632.38% 104.69% -4.07% -1.25% -3.40% 5.91%
EPS Q/Q Growth		 -14.02% -2.86% 9.27% -20.37% 2.28% -634.51% 104.63% -4.43% -0.56% -3.16% 7.53%
Operating Cash Flow Q/Q Growth		 79.01% -28.18% -15.31% 448.56% 147.06% 22.45% -9.74% -893.38% 63.94% 23.21% -29.54%
Free Cash Flow Firm Q/Q Growth		 64.11% -119.98% -76.21% 19.25% 393.62% 55.20% -71.04% -942.69% 43.81% 30.38% -69.12%
Invested Capital Q/Q Growth		 -2.99% -0.96% 1.94% -2.76% -16.37% -29.99% -3.39% 10.07% 4.03% -5.16% 2.51%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 10.16% 10.04% 10.75% 11.67% 12.09% 11.67% 11.13% 12.08% 11.86% 12.24% 13.44%
EBITDA Margin		 3.46% 3.17% 3.49% 3.26% 3.97% -0.97% 3.02% 4.28% 4.31% 4.05% 4.00%
Operating Margin		 3.15% 2.74% 2.47% 2.18% 2.92% -2.13% 1.95% 3.46% 3.59% 2.77% 2.80%
EBIT Margin		 3.08% 2.67% 2.79% 2.16% 2.92% -2.15% 1.95% 3.42% 3.54% 3.17% 3.00%
Profit (Net Income) Margin		 2.03% 1.80% 1.94% 1.05% 1.77% -6.32% 0.34% 2.52% 2.37% 2.36% 2.35%
Tax Burden Percent		 65.48% 66.26% 68.23% 52.58% 68.87% 268.41% 18.76% 74.86% 73.70% 77.18% 75.80%
Interest Burden Percent		 100.85% 101.40% 102.13% 92.10% 88.06% 109.79% 93.76% 98.19% 90.78% 96.47% 103.55%
Effective Tax Rate		 34.52% 33.74% 31.77% 43.76% 22.45% 0.00% 21.11% 25.23% 27.70% 22.82% 24.20%
Return on Invested Capital (ROIC)		 10.03% 8.52% 7.04% 3.80% 6.67% -4.71% 5.80% 9.87% 8.78% 6.70% 7.17%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.73% 10.02% 25.32% 0.46% -0.86% -92.11% -22.89% 8.24% 5.58% 12.52% -39.15%
Return on Net Nonoperating Assets (RNNOA)		 -1.91% -0.48% 1.55% 0.09% -0.20% -19.48% -4.27% 1.68% 1.72% 1.73% 0.64%
Return on Equity (ROE)		 8.12% 8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42% 7.82%
Cash Return on Invested Capital (CROIC)		 -3.03% -4.22% -5.53% -18.16% 12.55% 16.84% 11.66% -14.77% -5.46% 37.07% 3.30%
Operating Return on Assets (OROA)		 7.05% 6.38% 6.19% 3.74% 4.73% -3.48% 3.65% 6.69% 6.70% 5.38% 5.11%
Return on Assets (ROA)		 4.65% 4.29% 4.32% 1.81% 2.87% -10.25% 0.64% 4.92% 4.48% 4.01% 4.01%
Return on Common Equity (ROCE)		 8.12% 8.04% 8.59% 3.89% 6.47% -24.20% 1.53% 11.55% 10.49% 8.42% 7.82%
Return on Equity Simple (ROE_SIMPLE)		 8.09% 8.21% 8.27% 3.83% 6.30% -28.40% 1.48% 11.01% 9.92% 8.34% 0.00%
Net Operating Profit after Tax (NOPAT)		 66 64 60 39 73 -45 49 91 98 70 65
NOPAT Margin		 2.06% 1.81% 1.69% 1.23% 2.26% -1.49% 1.54% 2.59% 2.59% 2.14% 2.12%
Net Nonoperating Expense Percent (NNEP)		 -0.70% -1.50% -18.28% 3.34% 7.53% 87.40% 28.69% 1.63% 3.20% -5.82% 46.32%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - 6.19%
Cost of Revenue to Revenue		 89.84% 89.96% 89.25% 88.33% 87.91% 88.33% 88.87% 87.92% 88.14% 87.76% 86.56%
SG&A Expenses to Revenue		 6.56% 6.78% 7.43% 7.34% 7.52% 8.52% 7.85% 7.80% 7.54% 8.51% 9.44%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 7.01% 7.30% 8.28% 9.49% 9.17% 13.80% 9.18% 8.62% 8.27% 9.47% 10.64%
Earnings before Interest and Taxes (EBIT)		 99 95 99 68 95 -65 61 121 134 103 91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 111 112 125 103 129 -30 95 151 163 132 122
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.35 1.23 1.22 1.19 0.92 0.90 0.98 0.97 0.81 1.18 1.04
Price to Tangible Book Value (P/TBV)		 1.56 1.51 1.91 2.39 1.74 1.78 1.76 1.55 1.19 1.61 1.54
Price to Revenue (P/Rev)		 0.34 0.27 0.29 0.33 0.26 0.20 0.23 0.22 0.19 0.34 0.31
Price to Earnings (P/E)		 16.65 14.97 14.73 31.08 14.53 0.00 66.36 8.85 8.20 14.21 13.20
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 6.01% 6.68% 6.79% 3.22% 6.88% 0.00% 1.51% 11.30% 12.20% 7.04% 7.57%
Enterprise Value to Invested Capital (EV/IC)		 1.40 1.22 1.20 1.14 1.11 0.98 0.98 0.98 0.86 1.19 1.04
Enterprise Value to Revenue (EV/Rev)		 0.31 0.28 0.31 0.41 0.36 0.28 0.25 0.29 0.27 0.32 0.31
Enterprise Value to EBITDA (EV/EBITDA)		 8.85 8.73 8.76 12.56 9.18 0.00 8.36 6.74 6.30 7.99 7.85
Enterprise Value to EBIT (EV/EBIT)		 9.95 10.34 10.99 18.95 12.46 0.00 12.98 8.43 7.67 10.18 10.49
Enterprise Value to NOPAT (EV/NOPAT)		 14.84 15.26 18.14 33.43 16.11 0.00 16.43 11.15 10.48 15.11 14.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 13.05 18.76 11.51 52.30 73.82 4.65 6.82 0.00 0.00 2.83 8.51
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 8.57 5.21 8.18 0.00 0.00 2.73 32.18
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.02 0.11 0.15 0.34 0.40 0.39 0.20 0.34 0.36 0.16 0.15
Long-Term Debt to Equity		 0.01 0.10 0.12 0.29 0.35 0.31 0.19 0.32 0.36 0.15 0.14
Financial Leverage		 -0.18 -0.05 0.06 0.20 0.24 0.21 0.19 0.20 0.31 0.14 -0.02
Leverage Ratio		 1.74 1.87 1.99 2.15 2.25 2.36 2.39 2.35 2.34 2.10 1.95
Compound Leverage Factor		 1.76 1.90 2.03 1.98 1.98 2.59 2.24 2.30 2.12 2.03 2.02
Debt to Total Capital		 2.20% 10.25% 13.26% 25.23% 28.58% 28.10% 16.37% 25.16% 26.71% 13.48% 13.17%
Short-Term Debt to Total Capital		 1.48% 1.34% 3.18% 3.76% 3.32% 5.74% 0.90% 1.08% 0.56% 0.74% 0.88%
Long-Term Debt to Total Capital		 0.72% 8.91% 10.08% 21.48% 25.27% 22.36% 15.48% 24.09% 26.15% 12.74% 12.29%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 97.80% 89.75% 86.74% 74.77% 71.42% 71.90% 83.63% 74.84% 73.29% 86.52% 86.83%
Debt to EBITDA		 0.16 0.79 1.03 2.83 2.84 -8.94 1.50 1.79 2.02 1.09 1.13
Net Debt to EBITDA		 -0.93 0.24 0.58 2.58 2.69 -7.95 0.84 1.54 1.80 -0.31 0.09
Long-Term Debt to EBITDA		 0.05 0.69 0.78 2.41 2.51 -7.12 1.42 1.72 1.98 1.03 1.05
Debt to NOPAT		 0.27 1.38 2.13 7.54 4.98 -5.83 2.95 2.97 3.36 2.07 2.13
Net Debt to NOPAT		 -1.56 0.42 1.19 6.88 4.72 -5.18 1.66 2.55 2.99 -0.59 0.18
Long-Term Debt to NOPAT		 0.09 1.20 1.62 6.41 4.40 -4.64 2.79 2.84 3.29 1.95 1.99
Altman Z-Score		 4.58 4.63 4.09 3.35 3.25 3.00 3.45 3.50 3.56 4.09 3.78
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.08 2.10 1.95 1.92 2.11 1.67 1.66 1.87 2.11 2.10 2.01
Quick Ratio		 1.08 1.06 1.06 0.95 0.77 0.66 0.86 0.94 1.00 1.15 1.12
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -20 -32 -47 -185 138 162 97 -137 -61 386 30
Operating Cash Flow to CapEx		 363.75% 432.17% 1,072.17% 354.47% 276.56% 2,850.05% 4,941.47% -1,815.65% -358.44% 4,344.21% 1,355.89%
Free Cash Flow to Firm to Interest Expense		 -11.16 -14.97 -14.71 -20.33 10.50 13.29 14.07 -20.96 -3.09 29.61 3.71
Operating Cash Flow to Interest Expense		 42.03 24.58 29.51 2.72 1.22 14.89 16.85 -19.06 -1.81 28.52 14.02
Operating Cash Flow Less CapEx to Interest Expense		 30.47 18.89 26.76 1.95 0.78 14.37 16.51 -20.11 -2.31 27.86 12.99
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.29 2.39 2.22 1.73 1.62 1.62 1.87 1.96 1.89 1.69 1.71
Accounts Receivable Turnover		 6.52 6.54 5.96 4.93 5.56 6.31 6.23 5.44 5.11 4.88 5.00
Inventory Turnover		 5.47 5.73 5.84 4.96 4.97 5.34 6.05 5.72 4.87 4.50 5.28
Fixed Asset Turnover		 82.11 71.55 65.50 48.84 0.00 0.00 0.00 0.00 0.00 0.00 94.04
Accounts Payable Turnover		 6.27 6.55 6.47 5.20 5.44 5.71 5.14 4.60 4.75 4.47 4.44
Days Sales Outstanding (DSO)		 55.96 55.78 61.21 74.01 65.68 57.88 58.63 67.13 71.44 74.73 73.04
Days Inventory Outstanding (DIO)		 66.76 63.70 62.46 73.59 73.46 68.40 60.29 63.80 75.02 81.03 69.09
Days Payable Outstanding (DPO)		 58.26 55.75 56.43 70.23 67.13 63.89 70.98 79.33 76.82 81.60 82.27
Cash Conversion Cycle (CCC)		 64.47 63.74 67.25 77.37 72.01 62.38 47.93 51.60 69.64 74.16 59.86
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 706 802 909 1,133 1,069 861 812 1,040 1,199 883 918
Invested Capital Turnover		 4.86 4.70 4.17 3.10 2.95 3.16 3.77 3.81 3.38 3.13 3.38
Increase / (Decrease) in Invested Capital		 86 96 107 224 -65 -208 -49 228 159 -316 35
Enterprise Value (EV)		 986 979 1,092 1,297 1,184 846 797 1,019 1,030 1,053 956
Market Capitalization		 1,089 952 1,020 1,031 837 611 716 786 736 1,095 945
Book Value per Share		 $28.27 $30.18 $33.07 $33.88 $35.56 $26.76 $28.71 $31.96 $36.36 $37.41 $40.11
Tangible Book Value per Share		 $24.33 $24.57 $21.12 $16.87 $18.76 $13.51 $16.00 $20.12 $24.90 $27.53 $27.12
Total Capital		 827 863 965 1,159 1,280 943 874 1,078 1,235 1,068 1,044
Total Debt		 18 88 128 292 366 265 143 271 330 144 137
Total Long-Term Debt		 5.97 77 97 249 323 211 135 260 323 136 128
Net Debt		 -103 27 72 267 347 236 80 233 294 -41 11
Capital Expenditures (CapEx)		 21 12 8.85 7.00 5.80 6.39 2.36 6.85 9.98 8.56 8.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 536 594 599 670 800 509 432 683 841 558 571
Debt-free Net Working Capital (DFNWC)		 658 655 655 695 819 539 495 721 877 743 697
Net Working Capital (NWC)		 645 644 625 652 776 484 487 710 870 735 687
Net Nonoperating Expense (NNE)		 1.01 0.57 -9.04 5.65 16 147 38 2.55 8.43 -7.35 -6.97
Net Nonoperating Obligations (NNO)		 -103 27 72 267 154 182 80 233 294 -41 11
Total Depreciation and Amortization (D&A)		 12 17 25 35 34 36 34 30 29 28 31
Debt-free, Cash-free Net Working Capital to Revenue		 16.65% 16.78% 16.80% 21.17% 24.60% 16.71% 13.71% 19.35% 22.20% 17.11% 18.76%
Debt-free Net Working Capital to Revenue		 20.43% 18.51% 18.37% 21.97% 25.20% 17.67% 15.70% 20.43% 23.16% 22.80% 22.91%
Net Working Capital to Revenue		 20.05% 18.19% 17.51% 20.60% 23.89% 15.90% 15.45% 20.10% 22.98% 22.56% 22.61%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.29 $2.40 $2.74 $1.30 $2.25 ($7.59) $0.42 $3.48 $3.57 $3.10 $3.05
Adjusted Weighted Average Basic Shares Outstanding		 28.56M 26.47M 25.32M 25.52M 25.64M 25.38M 25.42M 25.50M 25.14M 24.87M 23.44M
Adjusted Diluted Earnings per Share		 $2.27 $2.38 $2.71 $1.29 $2.24 ($7.59) $0.42 $3.45 $3.54 $3.06 $3.00
Adjusted Weighted Average Diluted Shares Outstanding		 28.80M 26.69M 25.52M 25.62M 25.73M 25.38M 25.52M 25.76M 25.36M 25.22M 23.84M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 27.62M 25.63M 25.43M 25.59M 25.24M 25.36M 25.50M 25.19M 24.84M 24.03M 21.88M
Normalized Net Operating Profit after Tax (NOPAT)		 68 65 64 60 92 44 56 91 98 73 70
Normalized NOPAT Margin		 2.12% 1.84% 1.79% 1.88% 2.83% 1.45% 1.78% 2.59% 2.59% 2.24% 2.31%
Pre Tax Income Margin		 3.10% 2.71% 2.84% 1.99% 2.57% -2.36% 1.83% 3.36% 3.22% 3.06% 3.10%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 55.13 44.58 30.91 7.51 7.22 -5.35 8.86 18.52 6.78 7.94 11.38
NOPAT to Interest Expense		 36.96 30.22 18.73 4.25 5.58 -3.72 7.00 14.00 4.97 5.35 8.06
EBIT Less CapEx to Interest Expense		 43.57 38.89 28.16 6.74 6.78 -5.87 8.52 17.47 6.28 7.29 10.34
NOPAT Less CapEx to Interest Expense		 25.41 24.54 15.97 3.49 5.14 -4.24 6.66 12.95 4.46 4.69 7.03
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 28.69% 157.51% 30.16% 0.00% 16.46% -3.15% 0.00% 20.50% 17.43% 55.66% 148.88%

Quarterly Metrics And Ratios for ScanSource

This table displays calculated financial ratios and metrics derived from ScanSource's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 21,480,385.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 21,480,385.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 0.79
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -7.15% -12.50% -15.01% -21.23% -11.49% -15.52% -6.34% 8.95% -4.63% 2.54% 8.79%
EBITDA Growth		 -26.26% 4.88% -41.25% -17.21% -2.41% -44.05% 27.63% 18.86% 6.83% -10.79% -6.82%
EBIT Growth		 -31.44% 5.25% -48.99% -20.20% -4.25% -54.01% 34.22% 23.47% 14.80% -5.18% -1.37%
NOPAT Growth		 -25.29% -21.81% -48.54% -21.98% -32.86% -27.21% 28.45% 26.17% 46.35% -4.91% 0.98%
Net Income Growth		 -35.81% 27.17% -39.65% -14.44% 9.99% -47.89% 36.12% 24.81% 17.11% -3.28% -3.13%
EPS Growth		 -35.11% 27.72% -39.76% -13.16% 13.11% -45.74% 48.00% 31.82% 28.99% 7.14% 5.41%
Operating Cash Flow Growth		 293.01% 335.15% 192.04% 458.69% -52.07% -109.79% -58.75% -86.03% -48.22% 598.40% 8.01%
Free Cash Flow Firm Growth		 105.86% 156.24% 227.53% 337.89% 1,720.44% 30.56% -77.91% -104.61% -92.62% -99.55% -86.33%
Invested Capital Growth		 0.70% -8.61% -19.23% -26.37% -17.78% -13.48% -3.83% 3.95% 0.37% 1.55% 1.02%
Revenue Q/Q Growth		 -7.48% 0.97% -14.94% -0.86% 3.95% -3.62% -5.71% 15.33% -9.01% 3.63% 0.04%
EBITDA Q/Q Growth		 -10.41% 58.34% -50.37% 17.59% 5.61% -9.22% 13.20% 9.51% -5.08% -24.19% 18.24%
EBIT Q/Q Growth		 -13.10% 76.38% -58.09% 24.25% 4.26% -15.28% 22.30% 14.30% -3.06% -30.03% 27.22%
NOPAT Q/Q Growth		 -2.37% 12.94% -42.92% 23.96% -15.98% 22.45% 0.72% 21.76% -2.54% -20.44% 6.96%
Net Income Q/Q Growth		 -17.97% 112.07% -60.87% 25.69% 5.45% 0.47% 2.22% 15.25% -1.06% -17.03% 2.38%
EPS Q/Q Growth		 -19.74% 111.48% -61.24% 32.00% 4.55% 1.45% 5.71% 17.57% 2.30% -15.73% 4.00%
Operating Cash Flow Q/Q Growth		 712.89% -32.40% 153.31% -65.82% -18.10% -113.80% 1,167.58% -88.43% 203.61% 32.87% 131.35%
Free Cash Flow Firm Q/Q Growth		 108.37% 958.05% 89.78% 41.62% -35.98% -24.12% -67.89% -129.57% 202.48% -95.38% 876.71%
Invested Capital Q/Q Growth		 -6.53% -3.88% -13.59% -5.16% 4.37% 1.16% -3.95% 2.51% 0.77% 2.35% -4.45%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 12.15% 11.39% 12.55% 13.04% 13.10% 13.61% 14.22% 12.93% 14.53% 13.43% 13.97%
EBITDA Margin		 3.51% 5.50% 3.21% 3.80% 3.87% 3.64% 4.37% 4.15% 4.33% 3.17% 3.74%
Operating Margin		 2.75% 3.03% 2.33% 2.93% 2.27% 2.47% 3.17% 3.30% 3.50% 2.33% 3.02%
EBIT Margin		 2.67% 4.67% 2.30% 2.88% 2.89% 2.54% 3.29% 3.27% 3.48% 2.35% 2.99%
Profit (Net Income) Margin		 1.76% 3.70% 1.70% 2.16% 2.19% 2.28% 2.47% 2.47% 2.69% 2.15% 2.20%
Tax Burden Percent		 80.60% 81.72% 71.33% 70.92% 73.92% 86.52% 71.95% 73.06% 73.63% 84.92% 70.20%
Interest Burden Percent		 81.80% 97.00% 103.76% 105.58% 102.45% 103.81% 104.33% 103.60% 104.92% 107.87% 105.01%
Effective Tax Rate		 19.40% 18.28% 28.67% 29.08% 26.08% 13.48% 28.05% 26.94% 26.37% 15.08% 29.80%
Return on Invested Capital (ROIC)		 7.38% 7.89% 5.52% 6.51% 5.20% 6.42% 7.43% 8.13% 8.39% 6.37% 7.26%
ROIC Less NNEP Spread (ROIC-NNEP)		 5.76% 12.80% 5.75% 6.97% 9.03% 7.83% -6.36% 4.68% 22.65% 10.31% -8.30%
Return on Net Nonoperating Assets (RNNOA)		 1.62% 3.10% 0.82% 0.96% 1.01% 0.66% 0.07% -0.08% 0.14% 0.38% 0.04%
Return on Equity (ROE)		 9.00% 11.00% 6.35% 7.47% 6.21% 7.08% 7.50% 8.05% 8.53% 6.75% 7.30%
Cash Return on Invested Capital (CROIC)		 7.49% 16.66% 28.41% 37.07% 25.75% 20.12% 10.54% 3.30% 7.29% 5.91% 6.78%
Operating Return on Assets (OROA)		 5.10% 8.57% 4.23% 4.88% 4.95% 4.41% 5.59% 5.57% 5.97% 4.12% 5.22%
Return on Assets (ROA)		 3.36% 6.80% 3.13% 3.66% 3.75% 3.96% 4.19% 4.22% 4.61% 3.78% 3.85%
Return on Common Equity (ROCE)		 9.00% 11.00% 6.35% 7.47% 6.21% 7.08% 7.50% 8.05% 8.53% 6.75% 7.30%
Return on Equity Simple (ROE_SIMPLE)		 8.87% 9.25% 8.45% 0.00% 8.54% 6.99% 7.49% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 19 22 13 16 13 16 16 20 19 15 16
NOPAT Margin		 2.22% 2.48% 1.66% 2.08% 1.68% 2.13% 2.28% 2.41% 2.58% 1.98% 2.12%
Net Nonoperating Expense Percent (NNEP)		 1.62% -4.91% -0.22% -0.46% -3.83% -1.41% 13.79% 3.45% -14.26% -3.93% 15.56%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.95% - - - 1.53% 1.54% 1.87% 1.82% 1.47% 1.58%
Cost of Revenue to Revenue		 87.85% 88.61% 87.45% 86.96% 86.90% 86.39% 85.78% 87.07% 85.47% 86.57% 86.03%
SG&A Expenses to Revenue		 8.61% 7.56% 8.85% 9.18% 9.25% 9.89% 9.89% 8.81% 10.18% 10.19% 10.18%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 9.41% 8.35% 10.22% 10.11% 10.83% 11.14% 11.05% 9.63% 11.03% 11.09% 10.96%
Earnings before Interest and Taxes (EBIT)		 23 41 17 21 22 19 23 27 26 18 23
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 31 49 24 28 30 27 31 34 32 24 29
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.82 1.04 1.17 1.18 1.25 0.00 0.88 1.04 1.05 0.94 0.86
Price to Tangible Book Value (P/TBV)		 1.18 1.41 1.60 1.61 1.89 0.00 1.32 1.54 1.54 1.44 1.32
Price to Revenue (P/Rev)		 0.20 0.28 0.32 0.34 0.37 0.00 0.27 0.31 0.32 0.28 0.25
Price to Earnings (P/E)		 9.27 11.21 13.90 14.21 14.68 0.00 11.81 13.20 12.93 11.60 10.63
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 10.78% 8.92% 7.20% 7.04% 6.81% 0.00% 8.47% 7.57% 7.73% 8.62% 9.41%
Enterprise Value to Invested Capital (EV/IC)		 0.86 1.03 1.18 1.19 1.25 0.00 0.88 1.04 1.05 0.94 0.86
Enterprise Value to Revenue (EV/Rev)		 0.26 0.31 0.32 0.32 0.37 0.00 0.27 0.31 0.32 0.30 0.25
Enterprise Value to EBITDA (EV/EBITDA)		 6.29 7.19 7.95 7.99 8.80 0.00 6.80 7.85 7.86 7.39 6.55
Enterprise Value to EBIT (EV/EBIT)		 7.76 8.86 10.06 10.18 11.27 0.00 9.19 10.49 10.30 9.55 8.35
Enterprise Value to NOPAT (EV/NOPAT)		 10.48 12.88 14.75 15.11 18.16 0.00 13.07 14.80 13.77 12.76 11.09
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.02 5.67 3.63 2.83 3.58 0.00 4.96 8.51 10.73 6.99 5.85
Enterprise Value to Free Cash Flow (EV/FCFF)		 11.45 5.92 3.70 2.73 4.39 0.00 8.23 32.18 14.46 16.09 12.76
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.27 0.18 0.15 0.16 0.16 0.16 0.16 0.15 0.15 0.13 0.13
Long-Term Debt to Equity		 0.26 0.17 0.15 0.15 0.15 0.15 0.14 0.14 0.14 0.11 0.11
Financial Leverage		 0.28 0.24 0.14 0.14 0.11 0.08 -0.01 -0.02 0.01 0.04 0.00
Leverage Ratio		 2.24 2.15 2.06 2.10 2.01 1.88 1.90 1.95 1.91 1.90 1.95
Compound Leverage Factor		 1.83 2.09 2.14 2.22 2.06 1.95 1.98 2.02 2.00 2.05 2.05
Debt to Total Capital		 21.33% 15.03% 13.38% 13.48% 13.65% 13.61% 13.42% 13.17% 12.93% 11.56% 11.56%
Short-Term Debt to Total Capital		 0.71% 0.70% 0.72% 0.74% 1.09% 0.95% 0.92% 0.88% 0.92% 1.88% 1.88%
Long-Term Debt to Total Capital		 20.62% 14.33% 12.66% 12.74% 12.56% 12.66% 12.50% 12.29% 12.01% 9.69% 9.68%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 78.67% 84.97% 86.62% 86.52% 86.35% 86.39% 86.58% 86.83% 87.07% 88.44% 88.44%
Debt to EBITDA		 1.63 1.09 1.06 1.09 1.11 1.29 1.20 1.13 1.10 0.99 1.00
Net Debt to EBITDA		 1.35 0.80 -0.10 -0.31 0.00 0.29 -0.06 0.09 0.09 0.29 -0.02
Long-Term Debt to EBITDA		 1.57 1.04 1.00 1.03 1.02 1.20 1.12 1.05 1.02 0.83 0.84
Debt to NOPAT		 2.71 1.95 1.96 2.07 2.29 2.49 2.31 2.13 1.92 1.70 1.69
Net Debt to NOPAT		 2.25 1.43 -0.18 -0.59 0.01 0.55 -0.11 0.18 0.15 0.51 -0.03
Long-Term Debt to NOPAT		 2.62 1.86 1.86 1.95 2.11 2.32 2.15 1.99 1.78 1.43 1.41
Altman Z-Score		 3.67 4.12 4.07 3.93 3.88 0.00 3.65 3.66 3.84 3.66 3.48
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.15 2.30 2.20 2.10 2.03 2.11 2.07 2.01 2.16 1.96 1.86
Quick Ratio		 1.05 1.16 1.16 1.15 1.07 1.08 1.12 1.12 1.13 1.04 1.02
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 12 123 234 332 212 161 52 -15 16 0.72 7.07
Operating Cash Flow to CapEx		 4,040.30% 2,479.37% 6,617.81% 4,310.16% 1,887.58% -313.63% 4,648.98% 303.73% 969.14% 1,561.57% 2,974.20%
Free Cash Flow to Firm to Interest Expense		 2.09 36.74 117.04 159.00 100.68 81.79 28.18 -7.29 8.19 0.37 5.43
Operating Cash Flow to Interest Expense		 16.75 18.82 80.04 26.24 21.26 -3.14 35.98 3.64 12.13 15.85 54.76
Operating Cash Flow Less CapEx to Interest Expense		 16.33 18.06 78.83 25.63 20.13 -4.14 35.21 2.44 10.88 14.83 52.92
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.91 1.84 1.84 1.69 1.71 1.74 1.70 1.71 1.72 1.76 1.75
Accounts Receivable Turnover		 5.18 4.98 5.43 4.88 5.02 4.99 5.16 5.00 5.35 5.24 5.18
Inventory Turnover		 4.92 4.74 4.76 4.50 4.77 4.92 5.12 5.28 5.13 5.31 5.53
Fixed Asset Turnover		 0.00 0.00 96.03 0.00 0.00 0.00 90.68 94.04 92.23 97.06 96.78
Accounts Payable Turnover		 4.93 4.91 5.03 4.47 4.62 4.95 4.69 4.44 4.67 4.75 4.49
Days Sales Outstanding (DSO)		 70.48 73.25 67.20 74.73 72.72 73.19 70.73 73.04 68.28 69.68 70.45
Days Inventory Outstanding (DIO)		 74.16 77.07 76.69 81.03 76.58 74.14 71.30 69.09 71.12 68.73 65.98
Days Payable Outstanding (DPO)		 73.97 74.32 72.54 81.60 78.96 73.72 77.77 82.27 78.08 76.76 81.37
Cash Conversion Cycle (CCC)		 70.67 76.00 71.36 74.16 70.34 73.61 64.27 59.86 61.32 61.64 55.06
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,121 1,077 931 883 921 932 895 918 925 947 904
Invested Capital Turnover		 3.33 3.19 3.32 3.13 3.09 3.01 3.26 3.38 3.26 3.22 3.43
Increase / (Decrease) in Invested Capital		 7.75 -101 -222 -316 -199 -145 -36 35 3.40 14 9.16
Enterprise Value (EV)		 958 1,113 1,095 1,053 1,155 0.00 791 956 973 893 778
Market Capitalization		 753 989 1,109 1,095 1,154 0.00 798 945 963 857 780
Book Value per Share		 $36.84 $38.19 $37.51 $37.41 $38.32 $37.83 $38.43 $40.11 $41.77 $41.51 $42.19
Tangible Book Value per Share		 $25.62 $28.04 $27.61 $27.53 $25.39 $25.21 $25.79 $27.12 $28.53 $27.08 $27.60
Total Capital		 1,163 1,122 1,090 1,068 1,066 1,043 1,042 1,044 1,050 1,030 1,025
Total Debt		 248 169 146 144 146 142 140 137 136 119 118
Total Long-Term Debt		 240 161 138 136 134 132 130 128 126 100 99
Net Debt		 205 124 -13 -41 0.52 31 -6.53 11 11 36 -1.88
Capital Expenditures (CapEx)		 2.32 2.55 2.42 1.27 2.38 1.97 1.42 2.52 2.40 1.98 2.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 772 757 622 558 553 574 542 571 586 575 534
Debt-free Net Working Capital (DFNWC)		 815 802 781 743 698 684 688 697 711 658 654
Net Working Capital (NWC)		 806 795 773 735 686 674 678 687 701 639 635
Net Nonoperating Expense (NNE)		 3.98 -11 -0.29 -0.58 -3.94 -1.10 -1.36 -0.52 -0.80 -1.32 -0.65
Net Nonoperating Obligations (NNO)		 205 124 -13 -41 0.52 31 -6.53 11 11 36 -1.88
Total Depreciation and Amortization (D&A)		 7.31 7.36 6.84 6.89 7.57 8.23 7.59 7.20 6.30 6.28 5.80
Debt-free, Cash-free Net Working Capital to Revenue		 20.75% 21.08% 17.97% 17.11% 17.50% 18.98% 18.22% 18.76% 19.50% 19.00% 17.30%
Debt-free Net Working Capital to Revenue		 21.90% 22.33% 22.57% 22.80% 22.10% 22.64% 23.13% 22.91% 23.66% 21.77% 21.20%
Net Working Capital to Revenue		 21.68% 22.11% 22.34% 22.56% 21.73% 22.31% 22.81% 22.61% 23.33% 21.13% 20.58%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.62 $1.31 $0.51 $0.66 $0.70 $0.72 $0.75 $0.88 $0.90 $0.75 $0.79
Adjusted Weighted Average Basic Shares Outstanding		 24.89M 25.04M 25.03M 24.87M 24.15M 23.81M 23.28M 23.44M 22.02M 21.87M 21.31M
Adjusted Diluted Earnings per Share		 $0.61 $1.29 $0.50 $0.66 $0.69 $0.70 $0.74 $0.87 $0.89 $0.75 $0.78
Adjusted Weighted Average Diluted Shares Outstanding		 25.18M 25.33M 25.44M 25.22M 24.65M 24.22M 23.60M 23.84M 22.41M 22.11M 21.58M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 24.97M 25.17M 24.71M 24.03M 0.00 23.46M 22.60M 21.88M 21.94M 21.48M 20.32M
Normalized Net Operating Profit after Tax (NOPAT)		 19 22 15 16 17 17 17 20 19 16 17
Normalized NOPAT Margin		 2.22% 2.48% 2.03% 2.08% 2.16% 2.30% 2.37% 2.41% 2.61% 2.11% 2.16%
Pre Tax Income Margin		 2.19% 4.53% 2.39% 3.04% 2.96% 2.64% 3.44% 3.38% 3.65% 2.53% 3.14%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.19 12.29 8.65 10.31 10.63 9.64 12.65 12.65 13.44 9.25 17.58
NOPAT to Interest Expense		 3.48 6.53 6.25 7.44 6.18 8.10 8.75 9.33 9.97 7.80 12.46
EBIT Less CapEx to Interest Expense		 3.78 11.53 7.44 9.70 9.50 8.64 11.87 11.45 12.19 8.24 15.74
NOPAT Less CapEx to Interest Expense		 3.06 5.77 5.04 6.83 5.05 7.10 7.98 8.13 8.71 6.78 10.62
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 19.17% 32.72% 55.66% 90.36% 149.35% 152.45% 148.88% 133.89% 125.68% 131.77%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise, investor‑oriented read on ScanSource (SCSC) using the latest quarterly data and the last four years of quarterly results. The focus is on cash flow trends, profitability, and balance‑sheet strength to help gauge liquidity and potential capital allocation moves.

  • Positive operating cash flow in Q2 2026: Net cash from continuing operating activities was $30,841,000, turning solidly positive after a negative print in Q2 2025.
  • Revenue held up at a high level in Q2 2026: Operating revenue was $766,512,000, up modestly year over year from Q2 2025’s $747,497,000, indicating resilient top line amid recent fluctuations.
  • Net income remained profitable in Q2 2026: Net income from continuing operations was $16,493,000, contributing to positive quarterly earnings per share.
  • Free cash flow appears positive for the quarter: Cash from operations (~$30.8M) exceeded capex (~$2.0M), suggesting cash generation available for growth initiatives or debt management.
  • Balance sheet debt position improved versus the prior quarter: Long‑term debt declined to $99,797,000 in Q2 2026 from $126,047,000 in Q1 2026, signaling deleveraging alongside ongoing financing activity.
  • Strong accumulated profitability metric: Retained earnings stood at about $1.027B, reflecting a long track record of profitable operations retained within equity.
  • Gross margin remains modest but stable: Gross margin sits in the mid‑teens (roughly 13.4% in Q2 2026), indicating a stable profitability base without sharp margin expansion in the period.
  • Working‑capital context remains elevated: Accounts receivable and inventories are elevated relative to cash, suggesting ongoing working‑capital deployment to support revenue levels.
  • Net cash from financing activities was negative in Q2 2026: Net financing cash flow was about $(50,318,000), driven by debt repayments and shareholder activity (e.g., share repurchases), reducing cash from financing channels this quarter.
  • Net cash from investing activities was negative in Q2 2026: Net cash used for investing was about $(20,333,000), reflecting acquisitions and capital expenditures that reduce near‑term cash despite supportive operating cash flow.
05/29/26 01:30 PM ETAI Generated. May Contain Errors.

ScanSource Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ScanSource's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

ScanSource's net income appears to be on an upward trend, with a most recent value of $71.55 million in 2025, rising from $65.42 million in 2015. The previous period was $77.06 million in 2024. View ScanSource's forecast to see where analysts expect ScanSource to go next.

ScanSource's total operating income in 2025 was $85.20 million, based on the following breakdown:
  • Total Gross Profit: $408.65 million
  • Total Operating Expenses: $323.45 million

Over the last 10 years, ScanSource's total revenue changed from $3.22 billion in 2015 to $3.04 billion in 2025, a change of -5.5%.

ScanSource's total liabilities were at $879.20 million at the end of 2025, a 2.9% increase from 2024, and a 31.6% increase since 2015.

In the past 10 years, ScanSource's cash and equivalents has ranged from $19.31 million in 2019 to $185.46 million in 2024, and is currently $126.16 million as of their latest financial filing in 2025.

Over the last 10 years, ScanSource's book value per share changed from 28.27 in 2015 to 40.11 in 2025, a change of 41.9%.


Related Companies

Financial statements for NASDAQ:SCSC last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel